Cowen Remains Positive as Pfizer (PFE) Reports a 3Q Beat and raise

PFIZER REPORTS THIRD-QUARTER 2015 RESULTS

October 27, 2015 6:45 AM EDT

Third-Quarter 2015 Reported Revenues(1) of $12.1 Billion Increased 6% Operationally, Which Includes $0.3 Billion Reflecting One Month of Legacy Hospira U.S. Operations Third-Quarter 2015 Adjusted Diluted EPS(2) of $0.60 and Reported Diluted EPS(1) of $0.34, Which Includes One Month of Legacy Hospira U.S. Operations Third-Quarter 2015 Reported Revenues(1) for Pfizer-Standalone (Excluding Legacy Hospira) Increased 4% Operationally; Innovative Products Business Grew 21% Operationally, Primarily Driven by Prevnar 13 Adult and Ibrance Raised Midpoint of 2015 Financial Guidance Ranges for Reported Revenues(1) by $1.0 Billion and Adjusted Diluted EPS(2) by $0.11, Primarily Reflecting Strong Performance to Date and Improved... More

ViiV Healthcare Awards 23 Small Grants to Help Alleviate the Stigma of HIV and AIDS in the MSM and Transgender Community Globally

October 26, 2015 10:29 AM EDT

LONDON, October 26, 2015 /PRNewswire/ --

ViiV Healthcare today awarded its first round of small grants to support men who have sex with men (MSM) and transgender community-led interventions to reduce stigma and discrimination based on sexual orientation, gender identity/expression and/or HIV status. 23 non-governmental and community-based organisations will receive up to £25,000 per year over a two year period through the Positive Action for MSM and Transgender programme.

Grantees from the following countries were selected from 237 applications received from 79 countries:

Bolivia Canada El... More